Ketamine Conjugate (BSA)

Our Ketamine - BSA product is an Antigen Conjugate based on a BSA (Bovine Serum Albumin) carrier, attached to proprietary Ketamine derivatives.

• Western blotting.
• Enzyme-linked immunosorbent assay (ELISA).
• Dot blotting.

Ketamine is a drug used in human and veterinary medicine developed by Parke-Davis (today a part of Pfizer) in 1962. Its hydrochloride salt is sold as Ketanest, Ketaset, and Ketalar. Pharmacologically, ketamine is classified as an NMDA receptor antagonist. At high, fully anesthetic level doses, ketamine has also been found to bind to opioid μ receptors and sigma receptors.